|
|
Lung Cancer Screening & Treatment: What Comes Next?
|
|
Thursday, July 15, 2021 • 6:00pm ET
|
|
Objectives:
Opportunities borne from effective screening
Current lung cancer treatment options
Potential new lung cancer agents
Effective screening-to-treatment plans: what does it look like for a patient?
Future strategies for screening
|
|
|
|
Albert Rizzo, MD, FCCP FACP FAASM
Chief Medical Officer
American Lung Association
Clinical Asst. Professor of Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Philadelphia, PA
|
|
James L. Mulshine, MD
Professor, Internal Medicine
Associate Director, Institute of Translation Medicine
Rush University
Chicago, Il
|
|
Sandip Patel, MD
Associate Professor
Medical Oncology
UC San Diego
San Diego, CA
|
|
Jacob Sands, MD
Physician, Dana-Farber Cancer Institute
Instructor of Medicine, Harvard Medical School
Andrea Borondy Kitts
Boston, MA
|
|
Andrea Borondy Kitts
Lung Cancer and Patient Advocate
Rescue Lung Society
Amesbury, MA
|
|
M. Patricia Rivera, MD
Professor of Medicine
The University of North Carolina at Chapel Hill
Chapel Hill, NC
|
|
|
|
|
|
|